Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Sanofi and Regeneron Hit Asthma Phase III Endpoints With Dupixent

Sep 11 2017

• By Alex Shimmings

Peacock — Sanofi and Regeneron's Expanding Pipeline Pride • Source: Shutterstock

Related Content

Regeneron And Sanofi Antibody Discovery Deal To End

Aug 04 2017

Related Companies

Sanofi

Regeneron Pharmaceuticals, Inc.

GSK plc

Teva Pharmaceutical Industries Ltd.

Amgen, Inc.

AstraZeneca PLC

Additional Topics

Clinical Trials Research & Development Companies Respiratory BioPharmaceutical

More from Clinical Trials

More from R&D

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.